Clinical Severity Staging System May Aid Tx Selection for Meniere Disease
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 6, 2023 -- A three-factor, composite clinical severity staging system can optimize treatment selection for the management of Meniere disease, according to a study published online Aug. 25 in Otolaryngology -- Head and Neck Surgery.
Brevin J. Miller, from Washington University in St. Louis, and colleagues sought to identify clinically important factors associated with conservative treatment response in Meniere disease and to develop a composite clinical severity staging system. Seventy-eight patients were enrolled in the study.
The researchers found that 63 percent of patients were responsive to conservative therapies. Higher proportions of no or mild vertigo (24 percent) and none or mild comorbidity (27 percent) and a lower proportion of hearing loss (19 percent) were seen among responsive versus unresponsive patients. A three-stage system that consolidated these factors demonstrated a treatment response gradient ranging from 100 percent for stage 1 (11 patients), 64 percent for stage 2 (56 patients), and 18 percent for stage 3 (11 patients).
"A composite clinical severity staging system including these three factors can be used to optimize treatment selection and promote patient-centered management of Meniere's disease," the authors write.
One author reported being a consultant for Cochlear Ltd.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Membranous Labyrinth Distension Seen in MRI of Meniere Disease
TUESDAY, July 2, 2024 -- Distension of the membranous labyrinth is seen in histologic specimens from deceased patients with symptoms consistent with Meniere disease and in...
Sound Stimulation Aids Saccular Dysfunction With Meniere Disease
MONDAY, July 1, 2024 -- Sound stimulation of 75 dB at a frequency of 100 Hz leads to improvement in cervical vestibular-evoked myogenic potential (cVEMP) amplitude...
Bilateral Gene Therapy Safely Restores Hearing in Children Born Deaf
WEDNESDAY, June 5, 2024 -- For pediatric patients with autosomal recessive deafness 9 (DFNB9), bilateral gene therapy with adeno-associated virus (AAV) serotype 1 carrying human...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.